- Home
- World
- RPT: REVIEW - Russia's Biocad Awaits Approval of Drug Based on 2018 Nobel Prize Research Next Year
RPT: REVIEW - Russia's Biocad Awaits Approval Of Drug Based On 2018 Nobel Prize Research Next Year
Rukhshan Mir (@rukhshanmir) Published October 16, 2018 | 10:18 AM
MOSCOW (UrduPoint News / Sputnik - 16th October, 2018) Russian biotechnology company Biocad expects its cancer medicine that is based on research by 2018 Nobel laureates to be approved in the second quarter of next year, Dmitry Morozov, the Biocad president, told Sputnik in an interview.
On October 1, immunologists James Allison from the United States and Tasuku Honjo from Japan were announced this year's Nobel prize laureates in medicine. The two scientists separately discovered mechanisms that harness the human immune system to fight tumors.
The research is based on the idea that the human immune system has a complex system of switch-offs and brakes which regulate immune response to diseases. The two scientists separately discovered two mechanisms on how to release the brakes, the technology referred to as "immune checkpoint blockade." According to the Swedish academy, the treatment based on the checkpoint concept "has fundamentally changed the outcome for certain groups of patients with advanced cancer."
APPROVAL OF DRUG IN RUSSIA PLANNED FOR 2019
Earlier this month, Morozov said there would soon be a cancer medicine based on Allison and Honjo's research available in Russia. Answering the question how soon that would be, Morozov said the medicine is expected to receive approval in Russia next year.
"We expect the approval of our original drug Prolgolimab in the second quarter of 2019 - monoclonal antibody against PD-1 antigen," Morozov said.
PD-1, studied by Honjo, is one of the two antibodies which contribute to removal of the immune inhibition.
PLANT IN FINLAND TO BECOME WINDOW TO EUROPE
The company recently has signed an agreement with Greek company Win Medica, Mexico's Psicofarma and reached a supply deal with Julphar, one of the largest pharmaceutical manufacturers in the middle East and Africa.
"China and Japan are of high priority," Morozov said, answering a question on which markets the company sought to enter next.
Since September last year, the company has been actively working to localize its production in the Finnish city of Turku. Biocad is planning to complete the manufacturing site, set up a lab network, launch clinical studies in the European Union next year. First sales in Finland are expected to start in 2022, the official said.
The Finnish facility will become a window to the European market for Biocad.
"Yes, our plant in Finland will be specialized in production of our products for the EU market and other markets as well," the official explained.
The company is currently implementing multiple new projects in gene and cell therapy. In particular, Biocad is developing gene therapy to treat hemophilia and spinal muscular atrophy, working on several drug candidates based on CAR-T cells and building up its portfolio of next-in-class products based on monoclonal antibodies.
Related Topics
Recent Stories
CM lauds TCF's journey from 5 schools to 2000 across country
Zhao Shirin calls on Punjab Industries Minister
Immunization campaign to protect children from deadly diseases in full swing
Action taken against officers not recovering 85% tax: Secretary
Haiti transitional council sworn in after months of violence
IHC adjourns cipher case hearing against PTI founder till April 20,
Ukrainian village battles mines year after Russia forced out
Collective efforts needed to curb terrorism: Barrister Saif
China's Shenzhou-18 mission takes off bound for space station
Police arrest 4 suspects, recovered phones, bikes
Thousands of flights scrapped as French air traffic controllers strike
WWB directed to identify board’s land for revenue generation
More Stories From World
-
Haiti transitional council sworn in after months of violence
29 minutes ago -
Ukrainian village battles mines year after Russia forced out
37 minutes ago -
China's Shenzhou-18 mission takes off bound for space station
29 minutes ago -
Thousands of flights scrapped as French air traffic controllers strike
31 minutes ago -
India's IndiGo to buy 30 A350 planes: Airbus
31 minutes ago -
Scottish leader scraps coalition deal with Greens
37 minutes ago
-
Paris landmark Moulin Rouge's windmill sails collapse
46 minutes ago -
155 killed in Tanzania as heavy rains lash East Africa
46 minutes ago -
Heatstroke kills 30 in Thailand this year as Southeast Asia bakes
29 minutes ago -
China's Shenzhou-18 mission takes off bound for space station
28 minutes ago -
Car giants vie for EV crown at Beijing's Auto China show
28 minutes ago -
US economic growth slows significantly in first quarter
1 hour ago